Dr. James L. Southwell Jr., DO

Dr. Southwell practices at The University of Kansas Hospital in Kansas City, Kansas, part of The University of Kansas Health System.

Dr. Southwell's NPI, 1740306273, was assigned on March 22, 2007. Dr. Southwell holds Missouri license 2010034070.

Dr. Southwell's primary practice is The University of Kansas Hospital, at 4000 Cambridge Street, Kansas City, KS 66160 in Wyandotte County. The practice phone is (913) 588-5000.

Dr. Southwell's primary practice is The University of Kansas Hospital in Kansas City, Kansas, part of The University of Kansas Health System. Dr. Southwell is also affiliated with AdventHealth Shawnee Mission. The medical group on file is Kansas University Physicians. Dmand AI also links Dr. Southwell to 2 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Southwell practices, 5 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Southwell's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dmand AI has Dr. Southwell's licenses on file in 3 states: Missouri, Idaho and Kansas.

CMS data shows 812 Medicare services from Dr. Southwell across 9 procedure codes in 2024, for 364 Medicare patients. Medicare paid $48,448 for them.

CMS counts 364 Medicare patients who saw Dr. Southwell in 2024. The largest group is 65 to 74, with 173 patients. 75% of them have high cholesterol, and 74% have high blood pressure. 10% are also on Medicaid. Their average risk score is 1.72, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Southwell's median patient age at 70, with 58% women.

In 2024, Dr. Southwell wrote 2,373 Medicare Part D claims for 351 patients. 90% of them were for generic drugs. CMS names the drug for 2,172 of them, across 41 drugs with 11 or more claims each, at $280,013 in total drug cost. In 2023, CMS named 1,799 claims across 35 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 93 out of 100 for Dr. Southwell for performance year 2024, reported through an alternative payment model (APM). Dr. Southwell accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Southwell as offering telehealth.

Skin biopsy: 1 to 10 procedures (CMS shows small counts as a range)

CMS Open Payments shows 118 general payments to Dr. Southwell from 7 drug and device companies from 2018 to 2025. Food and beverage make up the largest share, 100% of the total. Pfizer Inc. paid the most, $632.